Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 07, 2022

SELL
$63.83 - $80.0 $167,745 - $210,240
-2,628 Closed
0 $0
Q1 2022

Apr 11, 2022

SELL
$76.85 - $89.45 $19,750 - $22,988
-257 Reduced 8.91%
2,628 $204,000
Q3 2021

Oct 12, 2021

SELL
$73.77 - $83.61 $8,114 - $9,197
-110 Reduced 3.67%
2,885 $232,000
Q1 2021

Apr 09, 2021

SELL
$76.38 - $86.03 $71,415 - $80,438
-935 Reduced 23.79%
2,995 $253,000
Q4 2020

Jan 12, 2021

SELL
$75.39 - $82.36 $24,501 - $26,767
-325 Reduced 7.64%
3,930 $315,000
Q3 2020

Oct 14, 2020

SELL
$78.33 - $90.73 $46,998 - $54,438
-600 Reduced 12.36%
4,255 $342,000
Q2 2020

Jul 09, 2020

SELL
$78.66 - $94.14 $44,678 - $53,471
-568 Reduced 10.47%
4,855 $418,000
Q1 2020

Apr 23, 2020

SELL
$71.57 - $93.3 $197,747 - $257,787
-2,763 Reduced 33.75%
5,423 $440,000
Q4 2019

Jan 14, 2020

SELL
$76.7 - $88.45 $72,865 - $84,027
-950 Reduced 10.4%
8,186 $685,000
Q3 2019

Oct 10, 2019

SELL
$81.4 - $89.78 $20,350 - $22,445
-250 Reduced 2.66%
9,136 $799,000
Q2 2019

Jul 18, 2019

SELL
$73.44 - $82.41 $15,348 - $17,223
-209 Reduced 2.18%
9,386 $769,000
Q1 2019

Apr 11, 2019

BUY
$64.48 - $81.31 $1,096 - $1,382
17 Added 0.18%
9,595 $780,000
Q3 2018

Oct 10, 2018

SELL
$70.71 - $77.75 $119,570 - $131,475
-1,691 Reduced 15.01%
9,578 $738,000
Q2 2018

Jul 13, 2018

SELL
$63.43 - $75.41 $58,672 - $69,754
-925 Reduced 7.59%
11,269 $832,000
Q1 2018

Apr 13, 2018

SELL
$62.56 - $72.26 $369,667 - $426,984
-5,909 Reduced 32.64%
12,194 $793,000
Q3 2017

Oct 13, 2017

BUY
$59.5 - $64.61 $1.08 Million - $1.17 Million
18,103
18,103 $1.14 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.3B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Legacy Private Trust Co. Portfolio

Follow Legacy Private Trust Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Private Trust Co., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Private Trust Co. with notifications on news.